Abstract
The intestinal microbiota is a vital organ – a participant in the processes of adaptation and evolution, an inducer of inflammation and the progression of aging. The key element of the interaction of intestinal microbiota with the body is lipopolysaccharides, the level of which in the general bloodstream increases significantly in so-called “microbiota-associated diseases”, which indicates the participation of endotoxin aggression in their pathogenesis, and most likely their initiation. One of the most common reasons for the development of endotoxin aggression may be quantitative and qualitative changes in the structure of the intestinal microbiota, leading to an increase in intestinal permeability, which are largely determined by nutritional factors. The antiendotoxin component in the treatment regimen for patients with various nosological forms of the diseases significantly increases the effectiveness of the treatment and prophylactic process, which can become one of the most promising areas of anti-aging measures.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
